Further research is also needed to further evaluate cortisol as a preclinical marker of AD risk, and to test the efficacy of HPA-based interventions, such as GR modulators and lifestyle stress-reduction techniques, for AD prevention. The gene discussed is NR3C1; the disease is Alzheimer disease.